Aventus Investment Advisors, Inc.: AMD position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Aventus Investment Advisors, Inc. on AMD, newest first. How the timeline and the estimate are built.
Aventus Investment Advisors, Inc. held 56 AMD shares at 2026-09-30 per its 13F-HR filed 2026-10-09.
the latest 13F is the newest step
- period ended2026-09-3013F 56 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $34,259.
13F-HR 0002093055-26-000004 filed by Aventus Investment Advisors, Inc.
Accepted , ingested - period ended2026-06-3013F 56 sharesChange vs previous 13F 0 shares
0.02% of the 13F portfolio, value $32,531.
13F-HR 0002093055-26-000003 filed by Aventus Investment Advisors, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 56 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $11,392.
13F-HR 0002093055-26-000002 filed by Aventus Investment Advisors, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 56 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $11,993.
13F-HR 0002093055-26-000001 filed by Aventus Investment Advisors, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 56 sharesChange vs previous 13F -70 shares
0.01% of the 13F portfolio, value $9,060.
13F-HR 0002093055-25-000002 filed by Aventus Investment Advisors, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 126 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $17,879.
13F-HR 0002093055-25-000003 filed by Aventus Investment Advisors, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).